30 years of research have proven the effectiveness of virtual reality.

Number of scientific publications listed on PubMed with the keywords “virtual reality” and “pain” or “anxiety”
Pain

Up to

83%

of reduction*

Anxiety

Up to

73%

of reduction*

Sedation

Up to

40%

of reduction in opioid use*

*compared to a control condition

Our results

10

usage studies carried out

10

published clinical studies

10

clinical studies in progress

Clinical studies on virtual reality

Clinical study

Study on the tolerance of virtual reality in nursing homes

92%

of tolerance and acceptance of the Lumeen device for elderly people with mild cognitive disorders in nursing homes

33 patients
Clinical study

Study on the effects of pain and anxiety management through virtual reality during painful care

Significant reduction

pain and anxiety during care during the VR phase compared to the control phase

120 patients
Clinical study

Study of Lumeen's interest in reducing preoperative anxiety in outpatient surgery

94.3%

of patients feel the favorable effects of virtual reality

94.4%

of health professionals are satisfied with the effects of the device on patients

106 patients
Satisfaction survey

Evaluation of the clinical benefits of Lumeen Relaxation during dialysis

57%

of patients observed a marked reduction in anxiety during the session

84%

Of increase
of well-being

78%

improving the experience during the session

272 patients
Satisfaction survey

Evaluation of the contribution of virtual reality to the service of embryo transfer

-50%

of patients who experienced pain during the embryo transfer

45 patients

Our impact measurement challenges

As a non-drug intervention

Environmental impact

Towards a more sustainable and responsible healthcare

Lumeen wants to contribute to medication sobriety and to the reduction of the carbon footprint associated with polluting anesthetics.

Anesthetic gases, such as desflurane, have a global warming power up to 2,500 times greater than CO₂, while some intravenous anesthetics can end up in water.

By integrating Lumeen as a complement or alternative to pharmacological products and medical gases, it is possible to reduce the use of substances with a high environmental impact and to contribute to a more eco-responsible hospital practice.

Medico-economic impact

Optimizing the patient journey and hospital resources

In many care pathways, virtual reality significantly reduces the use of medications, thus limiting their side effects. In some cases, it also reduces the need for medical equipment.

It also makes it possible to reduce the time spent in the post-interventional monitoring room, promoting faster patient turnover and better fluidity of care.

These combined effects can generate a positive return on investment for institutions and the healthcare system, while improving the patient experience.

Our ambition is to precisely measure these benefits over time in order to demonstrate that Lumeen can not only have a positive clinical and ecological impact, but also contribute to substantial savings for healthcare facilities.

Did you know ?

Virtual reality, recognized as a non-drug intervention (INM) by the Médéric Alzheimer Foundation

Non-drug interventions, recommended by the French Haute Autorité de Santé (HAS), contribute to the prevention of loss of autonomy.

The benefits of virtual reality have been demonstrated:
- Improvement of cognitive skills
- Reduction in psychobehavioral disorders
- Improvement of social interactions and quality of life

Consult the guidebook Non-drug interventions and Alzheimer's disease: understanding, knowing, implementing 2024 edition from the Médéric Alzheimer Foundation to learn more.